Toyoshi Inoguchi1, Ryoichi Takayanagi. Show Affiliations » 1. Department of Medicine and Bioregulatory Sicence, Postgraduate School of Medical Sciences, Kyushu University.
Abstract
Entities: Disease
Mesh： See more » Angiotensin II Type 1 Receptor Blockers/therapeutic useAngiotensin-Converting Enzyme Inhibitors/therapeutic useAnimalsAntioxidants/therapeutic useDiabetes Mellitus/metabolismDiabetic Angiopathies/drug therapyDiabetic Angiopathies/etiologyGlucose/metabolismGlycation End Products, Advanced/metabolismHexosamines/metabolismHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useMitochondria/metabolismNADPH Oxidases/metabolismOxidative Stress/physiologyPolymers/metabolismXanthine Oxidase/metabolism
Substances： See more » Angiotensin II Type 1 Receptor BlockersAngiotensin-Converting Enzyme InhibitorsAntioxidantsGlycation End Products, AdvancedHexosaminesHydroxymethylglutaryl-CoA Reductase InhibitorsPolymerspolyolXanthine OxidaseNADPH OxidasesGlucose
Year: 2008 PMID： 18536327
Source DB: PubMed Journal: Fukuoka Igaku Zasshi ISSN： 0016-254X